Clinical Trials Directory

Trials / Unknown

UnknownNCT04184908

Clinical Study New Gel for Xerostomia

Clinical Study to Evaluate the Efectiveness and Tolerability of a New Gel for Xerostomia

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Universidad de Murcia · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

At present, there is no single consensus protocol for the treatment of oral dryness, although the main objective is to improve the quality of life of patients. Current therapy for the control of xerostomia is based on the following measures: 1. General measures ; review and control of drugs,hydration and dietary advice: The main recommendations are found in the following scheme. 2. Saliva stimulants( Topics and sistemic )The option of using chewing stimuli by chewing gum with non-cariogenic sweeteners helps to improve symptoms. The investigators can also use gustatory stimuli, such as citric acid that is a potent stimulator of salivary secretion. Among the most commonly used pharmacological agents are: pilocarpine, bethanecol, civemiline 3. Saliva substitutes or artificial saliva. Saliva substitutes can provide a moisture retention layer in the oral mucosa and can be administered by liquids, spray, pills or gels. Topical treatments have few adverse effects and improve the quality of life of patients with xerostomia; In addition, they maintain oral health.

Detailed description

Randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and tolerability in patients with a non-commercialized gel and property of the promoter to treat xerostomia.

Conditions

Interventions

TypeNameDescription
DRUGgel xerostomiaApply 2-3 cm of the gel on the tongue, gums and oral mucosa, at least three times a day, if necessary it can be applied at night
OTHERgel placeboApply 2-3 cm of the gel on the tongue, gums and oral mucosa, at least three times a day, if necessary it can be applied at night

Timeline

Start date
2019-10-01
Primary completion
2019-11-02
Completion
2020-12-31
First posted
2019-12-04
Last updated
2019-12-05

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04184908. Inclusion in this directory is not an endorsement.